PURE Bioscience (OTCMKTS:PURE – Get Free Report)’s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.07 and traded as high as $0.07. PURE Bioscience shares last traded at $0.07, with a volume of 275 shares changing hands.
PURE Bioscience Stock Performance
The stock’s 50 day simple moving average is $0.07 and its 200 day simple moving average is $0.07. The firm has a market capitalization of $10.40 million, a P/E ratio of -2.67 and a beta of 0.21.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last announced its quarterly earnings results on Monday, June 15th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.51 million during the quarter.
PURE Bioscience Company Profile
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
See Also
- Five stocks we like better than PURE Bioscience
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
